GlobalData on MSN
FDA clears Cepheid’s Xpert GI Panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.
A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...
Predictive cancer diagnostics company Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of ...
News-Medical.Net on MSN
Alliance trial tests proactive chemotherapy dose adjustments for GI cancers
To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...
The Canadian Press on MSN
Some Kashechewan First Nation residents test positive for parasite amid evacuation
A least 28 people from a northern Ontario First Nation that was largely evacuated after the failure of its water system have ...
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built around it, is shifting fast. Here’s what five leaders have told ...
To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...
Developing slowly over months to years, feline small cell gastrointestinal (GI) lymphoma can be difficult to detect. 1 With this type of cancer resembling many of the common digestive issues cats ...
Canadian researchers say a blood test measuring immune response to gut bacteria could help predict Crohn’s disease years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results